ARCPOINT ANNOUNCES FAILURE-TO-FILE CEASE TRADE ORDER

ArcPoint announced a cease trade order due to failure to file financial documents, raising concerns among investors and regulators.

Galibra Neuroscience Receives FDA Orphan Drug And Rare Pediatric Disease Designations For SSADH Deficiency Gene Therapy

Galibra Neuroscience receives FDA orphan drug and rare pediatric disease designations for its SSADH deficiency gene therapy, advancing its development pipeline.

AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, As Preclinical Candidate (PCC) For Ocular Diseases, Inflammatory Disorders And Aging

Insilico Medicine announces ISM9077 as a potential first-in-class Y Inhibitor for ocular, inflammatory, and aging diseases, advancing AI-driven drug discovery.

You Won’t Believe How Sous Vide Precision Cooker Can Secure Your Future

No other kitchen gadget can guarantee such precision and consistency—discover how a sous vide cooker can truly secure your culinary future.

You Won’t Believe How Walk-In Bathtub Can Secure Your Future

Just imagine how a walk-in bathtub could safeguard your future—discover the surprising safety features that might change your life forever.

Walgreens 2026 Store Locations Closing

Walgreens plans to close numerous store locations across the US by 2026, as part of a strategic shift. Details on the number and affected areas are still emerging.

Michelle W Bowman: Responsible Innovation And Financial Inclusion

Federal Reserve’s Michelle Bowman emphasizes responsible innovation to promote financial inclusion, highlighting ongoing efforts and future priorities.

Brunswick Corporation Releases Investor Day Materials Highlighting Long-Term Growth Strategy

Brunswick Corporation released investor day materials emphasizing its long-term growth plans, signaling confidence in future expansion.